Table 2-.
Target | PDB ID/MODBASE |
Resolution or Template ( identity %) |
FTmap ligandability |
Ligand |
---|---|---|---|---|
LasI | 1RO5 | 2.3 | D | - |
RhlI | P54291 | 3P2H (38) | DPM | - |
PqsA | 5OE6 | 1.67 | D | 9SN |
PqsBC | 5DWZ | 2.04 | DPM | - |
PqsD | 3H76 | 1.8 | D | - |
3H77 | 1.8 | D | COW | |
PqsE | 3DH8 | 1.8 | D | B4N |
5HIO | 1.9 | BD | 61M | |
5HIP | 1.99 | D | 61O | |
5HIS | 1.77 | N | 60P | |
Target | PDB ID/MODBASE |
PockDrug druggability score* | Ligand | |
LasI | 1RO5 | 1.0 ± 0.0 | - | |
RhlI | P54291 | 0.5 ± 0.02 | - | |
PqsA | 5OE6 | 0.89 ± 0.04 | 9SN | |
PqsBC | 5DWZ | 0.89 ± 0.02 | - | |
PqsD | 3H76 | 0.9 ± 0.01 | - | |
3H77 | 0.8 ±0.04 | COW | ||
PqsE | 3DH8 | 0.73 ± 0.18 | B4N | |
5HIO | 0.6 ± 0.21 | 61M | ||
5HIP | 0.82 ± 0.17 | 61O | ||
5HIS | 0.56 ± 0.21 | 60P |
Only the main binding site (P0) was considered for apo structures or homology models (highlighted in gray)